SightfileU.S. market data from official filings
Companies › EPRX
EUPRAXIA PHARMACEUTICALS INC (EPRX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001581178 · EDGAR filings · Updated 2026-07-15
EUPRAXIA PHARMACEUTICALS INC (EPRX) has reported institutional ownership of 42.3%, with 54 institutional managers holding positions valued at $156.5M per the latest 13F reporting period.
Institutional ownership
42.3%
Institutional managers
54
Reported 13F value
$156.5M
Latest updates
- 2026-07-15 — Foreign issuer report (6-K) filed
- 2026-07-13 — Foreign issuer report (6-K) filed
- 2026-07-07 — Foreign issuer report (6-K) filed
- 2026-06-22 — Foreign issuer report (6-K) filed
- 2026-05-29 — Foreign issuer report (6-K) filed
- 2026-05-29 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, EUPRAXIA PHARMACEUTICALS INC has 54 institutional holders and institutional ownership of 42.3%.
Related companies
ORASURE TECHNOLOGIES INC (OSUR) · PULSE BIOSCIENCES INC (PLSE) · NIAGEN BIOSCIENCE INC (NAGE) · IMMUNEERING CORP (IMRX) · DELCATH SYS INC (DCTH) · ORGANOGENESIS HLDGS INC (ORGO)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.